Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma
Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Overexpression of Neutral Endopeptidase (NEP) has been reported in metastatic carcinomas, implicating NEP in tumor progression and suggesting a role for NEP inhibitors in its treatment. We investigated the role of NEP expression in the clinical progression of cutaneous melanoma.
We screened 7 melanoma cell lines for NEP protein expression. NEP-s...
Alternative Titles
Full title
Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c1f2150a4ce84fafb97b27eb8ea17951
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c1f2150a4ce84fafb97b27eb8ea17951
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/1479-5876-5-2
